TransEnterix (TRXC) Receives Analyst Rating

TransEnterix (TRXC) : The consensus on TransEnterix (TRXC) based on 3 analyst recommendation on the company stock is 1.33, which is interpreted as a Strong Buy recommendation. Zacks Investment Research has issued a rank of 2 which endorses a Buy on the stock. However, 2 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 1 analyst believes that the stock is a Buy, which can produce decent returns in the future.

TransEnterix (TRXC) : The consensus price target for TransEnterix (TRXC) is $3.58 for the short term with a standard deviation of $0.52. The most optimist securities analyst among the 3 who monitor the stock believes that the stock can reach $4, however, the pessimist price target for the company is $3.


TransEnterix (NYSEMKT:TRXC): The stock opened in the green at $1.56 on Thursday, but the bulls found it difficult to push the prices higher. The stock reached a high of $1.56 and a low of $1.43 for the day. The stock did not find buyers even at the lows and closed at $1.47 recording a loss of -5.16%. 501,637 shares exchanged hands during the trading day. The stock had closed at $1.55 in the previous days trading.

TransEnterix, Inc. is a medical device company focused on the development and commercialization of a robotic assisted surgical system called the SurgiBot System (the SurgiBot System). The Companys SurgiBot System is designed to utilize flexible instruments through articulating channels controlled directly by the surgeon with robotic assistance while the surgeon remains patientside within the sterile field. It has commercialized the SPIDER Surgical System, (the SPIDER System) a manual laparoscopic system in the United States, Europe and the Middle East. The SPIDER System utilizes flexible instruments and articulating channels that are controlled directly by the surgeon, allowing for multiple instruments to be introduced through a single site. It also offers Flex Ligating Shears (FLS) which is an energy device used with the existing SPIDER Surgical System. The FLS device is designed to deliver controlled energy to ligate and divide tissue.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.